HealthEquity (HQY) Tops Q2 EPS by 15c, Offers FY Guidance

HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.42, $0.15 better than the analyst estimate of $0.27. Revenue for the quarter came in at $176 million versus the consensus estimate of $171.28 million.

GUIDANCE:

HealthEquity sees FY2021 EPS of $1.48-$1.58, versus the consensus of $1.44. HealthEquity sees FY2021 revenue of $720-730 million, versus the consensus of $733.4 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• AXT appoints Tracy Liu to its board of directors